Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
Clinical trial NCT02493764 · COMPLETED
Trial details
- NCT number
- NCT02493764
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-24
- Primary completion
- 2019-04-03
- Enrollment
- 537
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.